Randomized phase II trial of extended versus standard neoadjuvant therapy for esophageal cancer, NCCTG (Alliance) trial N0849
   Google Scholar   
Citation:
J. Clin. Oncol. vol 31 (15 suppl) abstr 4026
Meeting Instance:
ASCO 2013
Year:
2013
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                   
Primary Study
N0849
Secondary Studies:
Phases:
2
Keywords: